biotime inc
(BTX:Consolidated issues listed on NYSE MKT LLC)
Executive Profile*
Michael D. West Ph.D.Chief Executive officer, President and Director, BioTime, Inc. |
| Age | Total Calculated Compensation | This person is connected to 21 board members in 4 different organizations across 9 different industries. See Board Relationships |
| 58 | $785,000 As of Fiscal Year 2012 |
Background*
Dr. Michael D. West, Mike, Ph.D., has been the the Chief Executive Officer of BioTime, Inc. since October 10, 2007 and serves as its President. Dr. West serves as the Chief Scientific Officer of LifeMap Sciences, Inc. He serves as the Chief Executive Officer of Embryome Sciences, Inc. He served as Consultant of Advanced Cell Technology Inc. since December 2007. Dr. West served as the Chairman of Advanced Cell Technology Inc. until November 2006 and also served as its ...
Corporate Headquarters*1301 Harbor Bay ParkwayAlameda, California 94502 United States Phone: 510-521-3390 Fax: 510-521-3389 Board Members Memberships*Former Chairman Member of the Scientific Advisory Board Former Chairman, President and Chief Scientific Officer Chief Scientific Officer, Director and Chief Executive Officer of Biotime Inc 2002-Present Chief Executive officer, President and Director 2012-Present Vice President of Technology Integration and Director
Education*PhD 1989 Baylor College of Medicine BS 1976 Rensselaer Polytechnic Institute MS 1982 Andrews University
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| BTX:US | $4.12 USD | +0.02 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Gil Van Bokkelen Ph.D. | Co-Founder, Chairman and Chief Executive Officer Athersys, Inc. | $537.5K |
| John A. Scarlett M.D. | Chief Executive Officer, President and Director Geron Corporation | $589.6K |
| Christopher J. Calhoun | Co-Founder, Vice Chairman, Chief Executive Officer, Secretary and Member of Executive Committee Cytori Therapeutics, Inc. | $467.9K |
| Robin L. Smith M.D., MBA,Ro | Executive Chairman and Chief Executive Officer Neostem, Inc. | $775.7K |
| Gary H. Rabin | Chairman of The Board, Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer and Member of Nominating & Corporate Governance Committee Advanced Cell Technology Inc. | $525.0K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
To contact BIOTIME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
